Skip to main content
Nishant Shah, MD, Cardiology, Durham, NC

NishantPrashantShahMDFACC

Cardiology Durham, NC

Preventive Cardiology

Physician

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shah's full profile

Already have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2016 - 2019
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2013

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2019 - 2024
  • OH State Medical License
    OH State Medical License 2016 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Journal Articles

  • Clinical Research Randomized Evaluation of Heart Failure with Preserved Ejection Fraction Patients with Acute Heart Failure and Dopamine: The ROPA-DOP Trial  
    Joban Vaishnav, David A Kass, Kavita Sharma, Nishant Shah, Allison Tsao, John Miller, Richa Gupta, David R Thiemann, Rohan Kalathiya, Steven P Schulman, Stuart D Russe..., ScienceDirect

Press Mentions

  • Wegovy and Other Weight Loss Drugs Shows Promise for Heart Disease
    Wegovy and Other Weight Loss Drugs Shows Promise for Heart DiseaseNovember 13th, 2023
  • FDA Approves Weight Loss Drug from Eli Lilly That Helped People Lose up to 52 Pounds
    FDA Approves Weight Loss Drug from Eli Lilly That Helped People Lose up to 52 PoundsNovember 10th, 2023
  • Zepbound Is Eli Lilly’s New Weight Loss Drug: What to Know
    Zepbound Is Eli Lilly’s New Weight Loss Drug: What to KnowNovember 10th, 2023

Professional Memberships